Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

NovaBay Pharmaceuticals (NBY) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for NovaBay Pharmaceuticals (NBY) over the last 16 years, with Q3 2025 value amounting to $6.0 million.

  • NovaBay Pharmaceuticals' Shares Outstanding rose 2305.02% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 2305.02%. This contributed to the annual value of $4.9 million for FY2024, which is 142180.69% up from last year.
  • According to the latest figures from Q3 2025, NovaBay Pharmaceuticals' Shares Outstanding is $6.0 million, which was up 2305.02% from $5.8 million recorded in Q2 2025.
  • NovaBay Pharmaceuticals' 5-year Shares Outstanding high stood at $44.9 million for Q3 2021, and its period low was $58000.0 during Q4 2022.
  • For the 5-year period, NovaBay Pharmaceuticals' Shares Outstanding averaged around $8.8 million, with its median value being $1.5 million (2022).
  • As far as peak fluctuations go, NovaBay Pharmaceuticals' Shares Outstanding plummeted by 9657.29% in 2022, and later soared by 252634.41% in 2024.
  • Over the past 5 years, NovaBay Pharmaceuticals' Shares Outstanding (Quarter) stood at $1.4 million in 2021, then plummeted by 95.75% to $58000.0 in 2022, then surged by 453.45% to $321000.0 in 2023, then surged by 1421.81% to $4.9 million in 2024, then grew by 23.05% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $5.8 million for Q2 2025, and $5.8 million during Q1 2025.